AtlasVoor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagLaat uw genoom in kaart brengen↗
Kenmerk
Self-injurious behavior
Self-aggression.
Samenvatting
- Ook bekend als
- Autoagression, Self injury, Self-harm, Self-injurious behaviors, Self-injurious behaviours
- Lichaamssysteem
- Abnormality of the nervous system
AtlasVoor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagLaat uw genoom in kaart brengen↗
Deze pagina als gegevens
Voeg .json toe aan het adres van de pagina, of vraag application/json aan, om haar als JSON te lezen.
library(jsonlite)
url <- "https://dantelabs.com/traits/self-injurious-behavior.json"
page <- fromJSON(url)
page$trait$nameSelf-injurious behaviorHP:0100716
AtlasVoor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagLaat uw genoom in kaart brengen↗
Lees de genen die aan Self-injurious behavior gekoppeld zijn, en de rest van uw genoom, met één test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen166 genen gekoppeld aan Self-injurious behavior
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Self-injurious behavior voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Altijd | In 1 aandoening |
| ASXL3ASXL transcriptional regulator 3 | Altijd | In 1 aandoening |
| CEP152centrosomal protein 152 | Altijd | In 1 aandoening |
| CRBNcereblon | Altijd | In 1 aandoening |
| ELP2elongator acetyltransferase complex subunit 2 | Altijd | In 1 aandoening |
| FOXP1forkhead box P1 | Altijd | In 1 aandoening |
| GLSglutaminase | Altijd | In 1 aandoening |
| GRIA1glutamate ionotropic receptor AMPA type subunit 1 | Altijd | In 1 aandoening |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Altijd | In 1 aandoening |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Altijd | In 4 aandoeningen |
| KARS1lysyl-tRNA synthetase 1 | Altijd | In 1 aandoening |
| KDM6Blysine demethylase 6B | Altijd | In 1 aandoening |
| KIF5Ckinesin family member 5C | Altijd | In 1 aandoening |
| LRRC7leucine rich repeat containing 7 | Altijd | In 1 aandoening |
| NEUROG1neurogenin 1 | Altijd | In 1 aandoening |
| RNU4-2RNA, U4 small nuclear 2 | Altijd | In 1 aandoening |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Altijd | In 1 aandoening |
| SLC6A17solute carrier family 6 member 17 | Altijd | In 1 aandoening |
| TM2D3TM2 domain containing 3 | Altijd | In 1 aandoening |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Altijd | In 1 aandoening |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Altijd | In 1 aandoening |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Heel vaak (80–99%) | In 1 aandoening |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Heel vaak (80–99%) | In 1 aandoening |
| MAGEL2MAGE family member L2 | Heel vaak (80–99%) | In 4 aandoeningen |
| MKRN3makorin ring finger protein 3 | Heel vaak (80–99%) | In 1 aandoening |
| NPAP1nuclear pore associated protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| PWAR1Prader Willi/Angelman region RNA 1 | Heel vaak (80–99%) | In 1 aandoening |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Heel vaak (80–99%) | In 1 aandoening |
| RAI1retinoic acid induced 1 | Heel vaak (80–99%) | In 1 aandoening |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Heel vaak (80–99%) | In 1 aandoening |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Heel vaak (80–99%) | In 1 aandoening |
| SYT1synaptotagmin 1 | Heel vaak (80–99%) | In 1 aandoening |
| AHDC1AT-hook DNA binding motif containing 1 | Vaak (30–79%) | In 1 aandoening |
| ATP6V0A1ATPase H+ transporting V0 subunit a1 | Vaak (30–79%) | In 1 aandoening |
| CASZ1castor zinc finger 1 | Vaak (30–79%) | In 1 aandoening |
| CHD8chromodomain helicase DNA binding protein 8 | Vaak (30–79%) | In 1 aandoening |
| CLCN3Cl-/H+ antiporter 3 | Vaak (30–79%) | In 1 aandoening |
| DHCR77-dehydrocholesterol reductase | Vaak (30–79%) | In 1 aandoening |
| DNM1dynamin 1 | Vaak (30–79%) | In 1 aandoening |
| EEF1A2eukaryotic translation elongation factor 1 alpha 2 | Vaak (30–79%) | In 1 aandoening |
Toon nog 126 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| FBXW11F-box and WD repeat domain containing 11 | Vaak (30–79%) | In 1 aandoening |
| FEM1Bfem-1 homolog B | Vaak (30–79%) | In 1 aandoening |
| GABBR2gamma-aminobutyric acid type B receptor subunit 2 | Vaak (30–79%) | In 1 aandoening |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Vaak (30–79%) | In 1 aandoening |
| HDAC4histone deacetylase 4 | Vaak (30–79%) | In 1 aandoening |
| HSPG2heparan sulfate proteoglycan 2 | Vaak (30–79%) | In 1 aandoening |
| IFNGinterferon gamma | Vaak (30–79%) | In 1 aandoening |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Vaak (30–79%) | In 1 aandoening |
| KPTNkaptin, actin binding protein | Vaak (30–79%) | In 2 aandoeningen |
| LUZP1leucine zipper protein 1 | Vaak (30–79%) | In 1 aandoening |
| MBD5methyl-CpG binding domain protein 5 | Vaak (30–79%) | In 2 aandoeningen |
| MMP23Bmatrix metallopeptidase 23B | Vaak (30–79%) | In 1 aandoening |
| MSL2MSL complex subunit 2 | Vaak (30–79%) | In 1 aandoening |
| NAA80N-alpha-acetyltransferase 80, NatH catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| NDNnecdin, MAGE family member | Vaak (30–79%) | In 3 aandoeningen |
| NDST1N-deacetylase and N-sulfotransferase 1 | Vaak (30–79%) | In 1 aandoening |
| NIPBLNIPBL cohesin loading factor | Vaak (30–79%) | In 1 aandoening |
| NRCAMneuronal cell adhesion molecule | Vaak (30–79%) | In 1 aandoening |
| NTNG2netrin G2 | Vaak (30–79%) | In 1 aandoening |
| OCA2OCA2 melanosomal transmembrane protein | Vaak (30–79%) | In 3 aandoeningen |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Vaak (30–79%) | In 1 aandoening |
| PDPNpodoplanin | Vaak (30–79%) | In 1 aandoening |
| POGZpogo transposable element derived with ZNF domain | Vaak (30–79%) | In 2 aandoeningen |
| PRDM16PR/SET domain 16 | Vaak (30–79%) | In 1 aandoening |
| PRKCZprotein kinase C zeta | Vaak (30–79%) | In 1 aandoening |
| RBL2RB transcriptional corepressor like 2 | Vaak (30–79%) | In 1 aandoening |
| REREarginine-glutamic acid dipeptide repeats | Vaak (30–79%) | In 2 aandoeningen |
| RNU2-2RNA, U2 small nuclear 2 | Vaak (30–79%) | In 1 aandoening |
| RPL10ribosomal protein L10 | Vaak (30–79%) | In 1 aandoening |
| SKISKI proto-oncogene | Vaak (30–79%) | In 1 aandoening |
| SLC32A1solute carrier family 32 member 1 | Vaak (30–79%) | In 2 aandoeningen |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Vaak (30–79%) | In 1 aandoening |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Vaak (30–79%) | In 3 aandoeningen |
| SPENspen family transcriptional repressor | Vaak (30–79%) | In 1 aandoening |
| SPOPspeckle type BTB/POZ protein | Vaak (30–79%) | In 1 aandoening |
| TSC1TSC complex subunit 1 | Vaak (30–79%) | In 1 aandoening |
| TSC2TSC complex subunit 2 | Vaak (30–79%) | In 1 aandoening |
| UBAP2Lubiquitin associated protein 2 like | Vaak (30–79%) | In 1 aandoening |
| UBE2Aubiquitin conjugating enzyme E2 A | Vaak (30–79%) | In 1 aandoening |
| UBE4Bubiquitination factor E4B | Vaak (30–79%) | In 1 aandoening |
| WASF1WASP family member 1 | Vaak (30–79%) | In 1 aandoening |
| WASHC4WASH complex subunit 4 | Vaak (30–79%) | In 1 aandoening |
| ZBTB20zinc finger and BTB domain containing 20 | Vaak (30–79%) | In 1 aandoening |
| ABCA12ATP binding cassette subfamily A member 12 | Soms (5–29%) | In 1 aandoening |
| ACBD6acyl-CoA binding domain containing 6 | Soms (5–29%) | In 1 aandoening |
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Soms (5–29%) | In 1 aandoening |
| ARXaristaless related homeobox | Soms (5–29%) | In 1 aandoening |
| ASPMassembly factor for spindle microtubules | Soms (5–29%) | In 1 aandoening |
| ATRXATRX chromatin remodeler | Soms (5–29%) | In 1 aandoening |
| BCL11ABCL11 transcription factor A | Soms (5–29%) | In 1 aandoening |
| BCORBCL6 corepressor | Soms (5–29%) | In 1 aandoening |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Soms (5–29%) | In 1 aandoening |
| CASKcalcium/calmodulin dependent serine protein kinase | Soms (5–29%) | In 1 aandoening |
| CDC42BPBCDC42 binding protein kinase beta | Soms (5–29%) | In 1 aandoening |
| CDH2cadherin 2 | Soms (5–29%) | In 1 aandoening |
| CDKL5cyclin dependent kinase like 5 | Soms (5–29%) | In 1 aandoening |
| CHD5chromodomain helicase DNA binding protein 5 | Soms (5–29%) | In 1 aandoening |
| CHKAcholine kinase alpha | Soms (5–29%) | In 1 aandoening |
| CLCN4Cl-/H+ antiporter 4 | Soms (5–29%) | In 1 aandoening |
| CREBBPCREB binding lysine acetyltransferase | Soms (5–29%) | In 2 aandoeningen |
| CTNNB1catenin beta 1 | Soms (5–29%) | In 1 aandoening |
| DCHS1dachsous cadherin-related 1 | Soms (5–29%) | In 1 aandoening |
| DMXL2Dmx like 2 | Soms (5–29%) | In 1 aandoening |
| DPYDdihydropyrimidine dehydrogenase | Soms (5–29%) | In 1 aandoening |
| EHMT1euchromatic histone lysine methyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| EP300EP300 lysine acetyltransferase | Soms (5–29%) | In 1 aandoening |
| FAT4FAT atypical cadherin 4 | Soms (5–29%) | In 1 aandoening |
| FMR1fragile X messenger ribonucleoprotein 1 | Soms (5–29%) | In 1 aandoening |
| GAMTguanidinoacetate N-methyltransferase | Soms (5–29%) | In 1 aandoening |
| GJB2gap junction protein beta 2 | Soms (5–29%) | In 1 aandoening |
| GNAO1G protein subunit alpha o1 | Soms (5–29%) | In 2 aandoeningen |
| GRM7glutamate metabotropic receptor 7 | Soms (5–29%) | In 1 aandoening |
| HECW2HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | Soms (5–29%) | In 1 aandoening |
| HNRNPH2heterogeneous nuclear ribonucleoprotein H2 | Soms (5–29%) | In 1 aandoening |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Soms (5–29%) | In 1 aandoening |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Soms (5–29%) | In 1 aandoening |
| KICS2KICSTOR subunit 2 | Soms (5–29%) | In 1 aandoening |
| KIF15kinesin family member 15 | Soms (5–29%) | In 1 aandoening |
| KMT2Clysine methyltransferase 2C | Soms (5–29%) | In 2 aandoeningen |
| LGI1leucine rich glioma inactivated 1 | Soms (5–29%) | In 1 aandoening |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Soms (5–29%) | In 1 aandoening |
| NDPnorrin cystine knot growth factor NDP | Soms (5–29%) | In 1 aandoening |
| NEUROD2neuronal differentiation 2 | Soms (5–29%) | In 1 aandoening |
| NFIXnuclear factor I X | Soms (5–29%) | In 1 aandoening |
| NIPA1NIPA magnesium transporter 1 | Soms (5–29%) | In 1 aandoening |
| NIPA2NIPA magnesium transporter 2 | Soms (5–29%) | In 1 aandoening |
| ODC1ornithine decarboxylase 1 | Soms (5–29%) | In 1 aandoening |
| PIDD1p53-induced death domain protein 1 | Soms (5–29%) | In 1 aandoening |
| PIGPphosphatidylinositol glycan anchor biosynthesis class P | Soms (5–29%) | In 1 aandoening |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Soms (5–29%) | In 1 aandoening |
| PNKPpolynucleotide kinase 3'-phosphatase | Soms (5–29%) | In 1 aandoening |
| PPFIA3PPFI scaffold protein A3 | Soms (5–29%) | In 1 aandoening |
| PPP2CAprotein phosphatase 2 catalytic subunit alpha | Soms (5–29%) | In 1 aandoening |
| RFX7regulatory factor X7 | Soms (5–29%) | In 1 aandoening |
| RHOBTB2Rho related BTB domain containing 2 | Soms (5–29%) | In 2 aandoeningen |
| RNU5B-1RNA, U5B small nuclear 1 | Soms (5–29%) | In 1 aandoening |
| RPS6KA3ribosomal protein S6 kinase A3 | Soms (5–29%) | In 1 aandoening |
| RTTNrotatin | Soms (5–29%) | In 1 aandoening |
| SCAF4SR-related CTD associated factor 4 | Soms (5–29%) | In 1 aandoening |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Soms (5–29%) | In 1 aandoening |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Soms (5–29%) | In 1 aandoening |
| SETBP1SET binding protein 1 | Soms (5–29%) | In 1 aandoening |
| SIK1salt inducible kinase 1 | Soms (5–29%) | In 1 aandoening |
| SLC25A22solute carrier family 25 member 22 | Soms (5–29%) | In 1 aandoening |
| SOX5SRY-box transcription factor 5 | Soms (5–29%) | In 1 aandoening |
| TAOK1TAO kinase 1 | Soms (5–29%) | In 1 aandoening |
| TBC1D23TBC1 domain family member 23 | Soms (5–29%) | In 1 aandoening |
| TCF4transcription factor 4 | Soms (5–29%) | In 2 aandoeningen |
| TKTtransketolase | Soms (5–29%) | In 2 aandoeningen |
| TMEM147transmembrane protein 147 | Soms (5–29%) | In 1 aandoening |
| TRIM8tripartite motif containing 8 | Soms (5–29%) | In 1 aandoening |
| TRIOtrio Rho guanine nucleotide exchange factor | Soms (5–29%) | In 1 aandoening |
| TUBG1tubulin gamma 1 | Soms (5–29%) | In 1 aandoening |
| VAMP2vesicle associated membrane protein 2 | Soms (5–29%) | In 1 aandoening |
| VPS13Avacuolar protein sorting 13 homolog A | Soms (5–29%) | In 1 aandoening |
| WACWW domain containing adaptor with coiled-coil | Soms (5–29%) | In 1 aandoening |
| WDR83OSWD repeat domain 83 opposite strand | Soms (5–29%) | In 1 aandoening |
| AFG2AAAA ATPase AFG2A | Zelden (1–4%) | In 1 aandoening |
| GJA5gap junction protein alpha 5 | Zelden (1–4%) | In 1 aandoening |
| GJA8gap junction protein alpha 8 | Zelden (1–4%) | In 1 aandoening |
| GRIA2glutamate ionotropic receptor AMPA type subunit 2 | Zelden (1–4%) | In 1 aandoening |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Niet vastgelegd | In 1 aandoening |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Niet vastgelegd | In 1 aandoening |
| KMT2Elysine methyltransferase 2E (inactive) | Niet vastgelegd | In 1 aandoening |
| MAOAmonoamine oxidase A | Niet vastgelegd | In 1 aandoening |
| RLIMring finger protein, LIM domain interacting | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.17-8666dff2.
AtlasVoor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagLaat uw genoom in kaart brengen↗
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken